Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1487 | Pituitary Clinical | ICEECE2012

Acromegaly and pregnancy: case reports

Abreu A , Rueda A

Acromegaly is a rare clinical disorder characterized by progressive somatic disfigurement and a wide range of systemic complications which include gonadotrophic dysfunction, menstrual abnormalities and infertility. Thus, pregnancy in patients with acromegaly is a rare and challenging medical situation. Furthermore, the evidence about the use of somatostatin analogs (SSAs) during pregnancy in patients with acromegaly and its outcomes is still limited. Here we describe the clini...

ea0032p381 | Diabetes | ECE2013

Trans-operative and post-operative medical complications in patients with diabetes mellitus type 2

Abreu Alin , Diaz Johann

Purpose: To determine the association between clinical indicators of metabolic state and cardiovascular, infectious and metabolic complications during or after elective surgery in patients with type 2 diabetes mellitus (T2DM) regardless of their treatment scheme.Methods: Prospective observational study. Patients with T2DM, ages 20–80 years, scheduled for elective surgery were evaluated with office BP, BMI, Hb1Ac, fasting glucose, fibrinogen, total c...

ea0049ep1005 | Pituitary - Clinical | ECE2017

Clinical characterization and comparison of patients with hipophysary tumors and primary empty sella

Abreu Alin , Casanova Maria Eugenia , Castano Orlando

Introduction: Non-functioning pituitary tumors and primary empty sella are a common pathology within the differential diagnosis of pituitary masses. The manifestations will depend on the size of the tumor and the compression of adjacent structures being the most frequent neurological symptoms. Clinically the two entities are very similar and no clinical tools are known to be able to help the differential diagnosis.Objective: Perform a clinical and compar...

ea0041gp216 | Thyroid - Translational & Clinical (1) | ECE2016

Endocrine toxicities of immune checkpoint inhibitors: a single centre experience

Gonzalez-Rodriguez Elisa , Rodriguez-Abreu Delvys

Introduction: Immune checkpoint inhibitors (ICI) are a new drug generation used for advanced neoplasias. They are monoclonal antibodies which enhance the immune system to combat cancer cells. As a result, immunologic tolerance can be altered and autoimmunity triggered. Toxicities associated to ICIs have been named immune-related adverse events (irAE). ‘Time to resolution’ of endocrine irAEs have not been well described as this term has not been defined in clinical tr...

ea0037ep807 | Pituitary: clinical | ECE2015

Macroprolactinomas invasive and its response to treatment in women. Cali - Colombia cohort study

Velasquez Paula Andrea , Mayor Adriana , Abreu Alin

Background: Orolactin-producing tumours are the most frequent pituitary tumours, representing 40% of these tumours, with an annual incidence of 6–10 cases/million. <10% are macroprolactinomas, which vary by age and gender, with female to male ratio of 10:1, however, less diagnosed in this population group.Objective: To describe clinical features and therapeutic response of 30 women with invasive macroprolactinoma.Methods: ...

ea0035p711 | Neuroendocrinology | ECE2014

Acromegaly and pregnancy: A descriptive case series

Orjuela Luis Fernanda , Valenzuela Alex , Abreu Alin

To describe the course of acromegaly in a group of seven women, before, during, and after pregnancy.Methods: Descriptive case series of acromegalic pregnant women attending a reference health center in Cali, Colombia.Results: Mean age at conception was 29±10 years, starting prenatal care at 10±3 weeks of gestation. 6 of 7 patients had a macroadenoma as evidenced by neuroimaging (MRI). 43% (three cases) had GH and prolacti...

ea0090p706 | Pituitary and Neuroendocrinology | ECE2023

Rare causes of adrenal tumours and the possible role of adrenal arterial embolization - two case reports

Manique Ines , Cortez Luisa , Abreu Silvestre , Silva-Nunes Jose

Introduction: Adrenal oncocytoma (AO) and ganglioneuroma (GN) are rare causes of adrenal masses, corresponding usually to nonfunctional and benign tumors. However, 20% of the AO shows some elements of malignancy and 10–20% of them affect adrenal hormone production. GNs account for 0.3%-2% of adrenal incidentalomas, with punctate calcifications in CT imaging being highly suggestive. However, preoperative differential diagnosis remains challenging. Adrenal arterial emboliza...

ea0049gp98 | Diabetes therapy &amp; complications 1 | ECE2017

Gestacional diabetes mellitus: the new screening criteria and its outcomes

Gouveia Pedro , Sa Maritza , Resende Eduarda , Ferreira Margarida , Abreu Silvestre

Background: Gestational Diabetes Mellitus (GDM) is one of the most common illness of pregnancy. Despite its frequency, there’s no worldwide accepted screening criteria for GDM. In 2011, Carpenter and Coustan (CC) screening (50-g glucose challenge test (GCT) followed by 100-g glucose tolerance test (OGTT) if GCT screen was positive) was abandoned and began the implementation of the screening of the International Association of Diabetes and Pregnancy Study Group (IADPSG) 20...

ea0049ep984 | Pituitary - Clinical | ECE2017

Invasive macroprolactinomas and its response to treatment in male patients

Abreu Alin , Hernandez Jose , Velasco Margarita , Triana Pablo , Castano Orlando

Introduction: Prolactin-producing pituitary adenomas are the most common pituitary tumors in clinical practice. In men they are more aggressive and their response to pharmacological treatment is unknown.Objective: Describe the clinical characteristics and response according to the treatment of a group of male patients with invasive macroprolactinomas.Materials and methods: A retrospective descriptive study, a series of cases, in 30...

ea0040p11 | (1) | ESEBEC2016

Acromegaly caused by hepatic metastasis of a pulmonary neuroendocrine tumor

Resende Eduarda , Gouveia Pedro , Sa Maritza , Ferreira Margarida , Abreu Silvestre

Introduction: Acromegaly is usually caused by a pituitary adenoma; ectopic or eutopic secretion of GHRH is a rare condition, responsible for <1% of the cases. Ectopic secretion of GH itself is even rarer.Case report: A 34-year-old woman was referred to the Endocrine Clinic with a multinodular goiter. However, on physical examination there were some physical signs of acromegaly: coarsening of facial features, protusion of the lower jaw and thick, oily...